Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5921-5930 of 11922

Edit search filters
  1. A Study To Evaluate ALN-6400 In Healthy Volunteers And Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

    Rochester, MN

  2. Study Of Orally Administered MOMA-341 In Participants With Advanced Or Metastatic Solid Tumors

    Scottsdale/Phoenix, AZ

  3. GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. To Compare The Efficacy And Safety Of The HAV With AVF In Female Patients With End-Stage Renal Disease Requiring Hemodialysis (HUMAXX)

    Jacksonville, FL

  5. EFS Of The CardioMech MVRS

    Rochester, MN

  6. A Study Of Engasertib In Moderate To Severe Hereditary Hemorrhagic Telangiectasia (HHT)

    Rochester, MN

  7. A Study Of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) In Participants With Chronic Lymphocytic Leukemia (CLL) And Other B-cell Malignancies

    Rochester, MN

  8. Global Prospective Case Series Using A Single-Use Duodenoscope

  9. Study To Check The Safety Of Fazirsiran And Learn If Fazirsiran Can Help People With Liver Disease And Scarring (Fibrosis) Due To An Abnormal Version Of Alpha-1 Antitrypsin Protein

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Safety And Tolerability Of TNG456 Alone And In Combination With Abemaciclib In Patients With Solid Tumors With MTAP Loss

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer